01 Expansion of AI-Assisted Radiology Triage AI in radiology market analysis shows that AI is being used in radiology to review medical imaging and identify potentially urgent findings. Deep learning and machine learning (ML) can help prioritize scans with suspected abnormalities for faster radiologist attention. This development strengthens clinical decision support within the radiology workflow.
02 Development of AI-based Radiology Report Generation AI systems are being used to analyze imaging findings and generate draft radiology reports for clinician review. Natural language capabilities can organize image analysis results into structured documentation and support faster reporting. This development improves efficiency across imaging informatics and diagnostic imaging workflows.
01 Supply chain disruptions are expected to have a moderate impact on the AI in radiology market share, as dependence on GPUs, high-bandwidth memory, imaging hardware, cloud infrastructure, and specialized computing components can increase deployment costs and delay installation of AI-enabled radiology systems. The market is likely to follow a stair-step recovery pattern, as hardware procurement, software integration, clinical validation, and hospital deployment can resume in phases as computing capacity and imaging-system availability improve. The market is expected to grow at a CAGR of 25.37%, but supply chain constraints could approximately lower this by 0.3 percentage points, resulting in short-term growth of around 25.07%. As supply conditions normalize through improved AI-chip availability, greater computing capacity, steadier imaging-hardware supplies, and smoother hospital technology integration, AI in radiology market growth is expected to gradually return 25.37%.
01 The AI in radiology market forecasts investments directed toward AI-powered medical imaging, automated radiology diagnosis, clinical workflow platforms, and advanced image-analysis tools.
02 Key Investment and Funding Activities in AI in Radiology Market, 2025–2026 Company Value (USD) Details Aidoc USD 150 million in Series E funding In April 2026, Aidoc raised another USD 150 million in Series E funding led by Goldman Sachs Alternatives, bringing its total funding to more than USD 500 million to scale its clinical AI foundation model and enterprise platform for medical imaging and clinical decision-making. Subtle Medical USD 33 million in Series C funding In May 2026, Subtle Medical raised USD 33 million in Series C funding. The company develops AI solutions for MRI, PET, and CT workflows, with the funding supporting further expansion of its imaging-AI portfolio. Aidoc USD 150 million In July 2025, Aidoc secured USD 150 million in financing, led by General Catalyst and Square Peg, to accelerate development of its CARE clinical AI foundation model and expand deployment of AI-powered solutions across healthcare systems.
01 Higher Medical Imaging Volumes and Expansion in Precision Medicine Programs Drive Market Higher volumes of X-rays, CT scans, MRI examinations, and other diagnostic imaging procedures are increasing the workload of radiology departments. AI-based image analysis can help process large numbers of scans, identify potential abnormalities, and support faster review. This growing imaging workload creates greater demand for AI-assisted diagnosis and clinical decision support.The expansion of precision medicine programs is increasing the need for detailed analysis of patient-specific imaging data. AI can identify imaging patterns and quantitative features that support individualized diagnosis and treatment decisions. Greater use of personalized healthcare therefore creates additional applications for AI in radiology.
01 PACS Integration Gaps and High AI Validation Costs Restrain Market Expansion Limited interoperability with legacy picture archiving and communication systems (PACS) and hospital systems can make AI deployment difficult across existing radiology workflows. Different data formats, interfaces, and system architectures may require additional integration work before AI tools can access medical imaging data. These compatibility issues can increase implementation effort and slow adoption across healthcare facilities.High costs for AI validation and clinical integration can increase the investment required by radiology providers. AI solutions need performance testing, clinical validation, workflow configuration, and ongoing monitoring before routine use. These requirements can make adoption more difficult for smaller hospitals and diagnostic imaging centers.
01 Adoption of AI-based Quantitative Imaging and Incidental Finding Detection Offer Growth Opportunities to Market Players The adoption of AI-based quantitative imaging offers growth opportunities for AI software developers, medical imaging technology companies, radiology workflow providers, and diagnostic imaging centers. These players can develop solutions that automatically measure anatomical structures, tissue characteristics, lesion volumes, and other imaging biomarkers, enabling more standardized and reproducible analysis. AI-based quantitative tools can also support risk assessment and opportunistic screening, creating opportunities for integrated imaging-analysis platforms.The use of AI for incidental finding detection offers growth opportunities for radiology AI developers, imaging software vendors, PACS/workflow providers, and healthcare technology companies. AI solutions can identify and prioritize clinically significant abnormalities detected during imaging performed for unrelated conditions, creating opportunities for tools that integrate alerts and findings directly into radiologists’ worklists. Recent clinical research has demonstrated the use of AI to flag incidental pulmonary embolisms and reduce the time required to prioritize such cases.
01 False-Positive Burden and Changing Clinical Data Conditions Challenge Market Growth False-positive findings from AI-assisted diagnosis can increase the number of cases requiring additional radiologist review. Frequent incorrect alerts may add workload to the radiology workflow and reduce confidence in automated findings. Higher review requirements can limit the efficiency gains expected from healthcare AI.The changing patient populations, disease patterns, and imaging practices can affect the performance of machine learning (ML) models after deployment. Differences in medical image analysis data over time may require model monitoring, recalibration, or retraining. These ongoing changes can make consistent AI performance more difficult to maintain.